The development and clinical validation of a turbulent-flow liquid chromatography-tandem mass spectrometric method for the rapid quantitation of docetaxel in serum

Clin Chim Acta. 2013 Feb 18:417:12-8. doi: 10.1016/j.cca.2012.11.021. Epub 2012 Nov 29.

Abstract

Background: Docetaxel is a second generation taxane utilized as an anti-neoplastic agent in cancer chemotherapies. Traditional treatment regimens have resulted in significant adverse effects, resulting in the shift to more frequent drug administration at lower doses. As a result, it is important to monitor serum docetaxel concentrations to optimize efficacy and minimize adverse effects.

Methods: Serum containing docetaxel was combined with acetonitrile containing deuterated internal standard, and following protein precipitation, supernatant was diluted with water for on-line sample extraction. Following turbulent-flow chromatography (TFC), analytic separation was achieved on a Hypersil Gold C-18 (50×2.1mm) column and the eluent analyzed using a TSQ Vantage mass spectrometer with selected reaction monitoring. Matrix effects were characterized in addition to carryover, precision, linearity, recovery and functional sensitivity.

Results: The simple and complex precision for the assay at multiple concentrations was ≤6.2%. The assay has functional sensitivity of <3ng/ml, and is linear from 8.1 to 1978ng/ml. Method comparison studies with a reference HPLC-MS/MS method show a slope of 0.84 with a Spearman coefficient of 0.99.

Conclusions: Based on the validation metrics, we have generated a sensitive and automated TFC-MS/MS method for docetaxel quantitation in serum.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Antineoplastic Agents / blood*
  • Antineoplastic Agents / isolation & purification
  • Blood Chemical Analysis / methods*
  • Chromatography, Liquid / methods*
  • Docetaxel
  • Humans
  • Limit of Detection
  • Linear Models
  • Tandem Mass Spectrometry / methods*
  • Taxoids / blood*
  • Taxoids / isolation & purification
  • Time Factors

Substances

  • Antineoplastic Agents
  • Taxoids
  • Docetaxel